|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Interest earned on investments held in Trust Account | ||
| Change in fair value of warrant liabilities | ||
| Transaction cost incurred in connection with the initial public offering | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Prepaid income taxes | ||
| Due to shareholders | ||
| Accrued expenses | ||
| Net cash provided by (used in) operating activities | ||
| Investment of cash into Trust Account | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash into Trust Account | ||
| Cash withdrawn from Trust Account to pay franchise and income taxes | ||
| Cash withdrawn from Trust Account in connection with redemption | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placement Units | ||
| Proceeds from promissory note - related party | ||
| Repayment of promissory note - related party | ||
| Redemption of common stock | ||
| Payment of offering costs | ||
| Net cash (used in) provided by financing activities | ||
| Net Change in Cash | ||
| Cash – Beginning of period | ||
| Cash – End of period | ||
| Supplementary cash flow information: | ||
| Cash paid for income taxes | ||
| Non-Cash Investing and Financing Activities: | ||
| Offering costs paid by Sponsor in exchange for issuance of Founder Shares | ||
| Deferred underwriting fee payable |
Loading...
